Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

MTS is spinning off its IT business into a separate company

12/18/24 MTSS

Moscow Exchange launched SAPFIR trading and clearing system

12/17/24 MOEX

Fix Price launched delivery in Belarus

12/17/24 FIXP

MD Medical opened a new clinic in Moscow

12/17/24 MDMG

Delimobile will launch a car repair business line

12/17/24 DELI

Ozon and SDEK started opening joint PVZ

12/17/24 OZON

Shareholders of RPA Nauka approved dividends

12/17/24 NAUK

MTS President may leave his post

12/17/24 MTSS

Sibur's Board of Directors approved the IPO

12/17/24 SIBR

Shareholders of Lenzoloto approved dividends

12/16/24 LNZL